Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
TipRanks on MSN

‘Bright Outlook Ahead,’ Says Top Mizuho Analyst on AMD Stock

Mizuho Securities analyst Vijay Rakesh reiterated his Buy rating on Advanced Micro Devices ($AMD) stock and raised his price ...